Translational Pathology Core

The mission of the TPC is to facilitate high-impact cancer research by providing high-quality tissue procurement, processing, and banking resources to USC Norris investigators working on all aspects of cancer research. TPC team members work with USC Norris investigators on the planning, design, and feasibility of cancer research studies requiring human biospecimens and play a key role in procuring tissue for USC Norris clinical trials. TPC serves as a key infrastructural element in providing human biospecimens for all five USC Norris Research Programs.

TPC Services

- - Procurement, processing, tracking, and distribution of formalin-fixed, paraffin embedded (FFPE) tumor tissue from USC Norris hospitals including Los Angeles General Medical Center, Keck Hospital, Norris Cancer Hospital, and CHLA.
  - Procurement, processing, tracking, and distribution of fresh/frozen tissue. This has been greatly enhanced by the new biobanking informatics platform, OpenSpecimen.
  - Immunohistochemistry/Immunofluorescence, including new antibody validation.
  - Design and construction of tissue micro-arrays (TMAs) including a new automated TMA instrument.
  - Whole slide scanning and image analysis/AI New Service.
  - Full range of histology services including custom embedding and processing.
  - Processing blood for serum, plasma, and peripheral blood mononuclear cells (PBMC).
  - Ficoll-hypaque blood/bone marrow specimens.
  - Processing urine, cerebrospinal fluid and other body fluids.
  - Consultation for design and feasibility.
  - Sub-specialty Anatomic Pathology review.

The TPC ensures the rigorous conduct of USC Norris research by:

- - Requiring IRB approval for all studies.
  - Ensuring that signed Informed Consent has been obtained.
  - Ensuring that all biospecimens utilized in clinical trials are handled according to CLIA/CAP regulations.

TPC Policies

- - TPC is accessible to all USC Norris members. The TPC director engages in outreach among USC Norris members through Grand Rounds and at USC Norris program meetings to increase usage.
  - USC Norris full members receive a 20 % subsidy.
  - TPC will provide an initial free consultation to those requesting Core services to determine the feasibility and scope of a project. The potential outputs of the initial consultation period will be a feasibility assessment, project scope, and project plan including cost estimate and timeline. Once the project plan is developed and agreed upon, all further activities will generate Core charges.
  - Mechanisms are in place to ensure that the TPC has the appropriate recharge account numbers in place prior to initiating a study. It is expected that appropriate and adequate funding support for TPC services is included in all grant applications and proposals.
  - USC Norris program members are encouraged to discuss study design and number of specimens needed for grant proposals as early as possible in the grant writing process to ensure feasibility of acquiring the specimens and the necessary costs.
  - Acknowledgment of the Norris Comprehensive Cancer Center CCSG grant (NCI grant # P30CA014089) in scientific manuscripts is required when TPC services have been provided.

Contact Us:

Kyle Hurth, M.D., Ph.D.
Director Translational Pathology Core
kyle.hurth@med.usc.edu

Ronald Vaca, HTL (ASCP)^CM
Manager Translational Pathology Core
ronald.Vaca@med.usc.edu
(323) 442-0368

William Dean Wallace, M.D.
Digital Pathology Services
william.Wallace@med.usc.edu

Sergei Tatishchev, M.D.
Image Analysis Services
sergei.Tatishchev@med.usc.edu

Anthony Tran, HTL (ASCP)^CM
Manager of Digital Pathology Services
anthony.Tran@med.usc.edu
(323) 442-1184

TPC Leadership

Kyle Hurth, M.D., Ph.D.

Director

kyle.hurth@med.usc.edu

Pediatric Tissue Service

Jennifer Cotter, MD

Supervisor

Director of Pediatric Biorepository,

Children’s Hospital Los Angeles

jcotter@chla.usc.edu

Monica Mendez

Manager

momendez@chla.usc.edu

An NCI-designated Comprehensive Cancer Center